Genetic testing for BRCA1 and BRCA2 mutations

BRCAaccuTest ™ and BRCAaccuTest ™ PLUS are a reagent kit for producing libraries to analyze BRCA1 and BRCA2 genes using the next generation sequencing (NGS) method, which analyzes genomic DNA derived from blood or FFPE tissue.

  • For patients with breast and ovarian cancer
  • For HBOC (Hereditary Breast and Ovarian Cancer Syndrome) patients
  • For family history or age of incidence of breast cancer


Certification: CE-IVD

Target disease: 

  • Breast / ovarian cancer,
  • HBOC (Hereditary Breast and Ovarian Cancer Syndrome)

Target enrichment method: Amplicon-based method


  • test 12 (6 + 6): (1 test each for DNA control)
  • 24 tests: (1 test for DNA control)

Sample: Blood, FFPE tissue, tissue biopsy

Amount of input DNA: 10-30 ng

Target gene: BRCA1 / BRCA2

Target region: 22.4 kb (all protein-coding regions, splice regions, selected promoter, UTR, intron regions)

Amplicon: 160 (2 groups)

Hands-on time: > 5 hours

Variant type: SNV, In, Del, Dup, CNV *

NGS Platform and Reagent Kit: Illumina MiSeq, MiSeq Dx / MiSeq Reagent Nano, Micro kit, v2, 300 cycles

Sample Yield: Germline (11) / Somatic (5) Germline (23)

Analysis Solution: NGeneAnalySys ™ (CE)